Austin cancer fighters halt drug development after deaths

halt drug development Austin’s Mirna Therapeutics announced that they will be stopping the development of their cancer-fighting drug MRX34. The reason for the shutdown is because of the recorded deaths in the Phase I study. The company has already halted the research and development of the drug and currently cutting down employees and expenses. According to the CEO of the company, it was a hard decision to stop the development of MRX34 because they have been working on it for almost a decade. The company is also considering other options regarding the future of the company, whether a sale or do a reverse merger to keep the company afloat.

Read more about this here: Austin cancer fighters halt drug development after deaths

Why use our services

You Save Time
Find the best spaces
Avoid costly mistakes
Get the best deal
Free Service!
Scroll to Top

FREE Report of Available Spaces!

Receive a free list of available spaces custom to your needs complete with lease rates, photos, and floor plans: